2011
DOI: 10.1016/j.tetasy.2011.02.012
|View full text |Cite
|
Sign up to set email alerts
|

Two procedures for the syntheses of labeled sialic acids and their 1,7-lactones

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
24
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
5

Relationship

3
2

Authors

Journals

citations
Cited by 15 publications
(25 citation statements)
references
References 14 publications
1
24
0
Order By: Relevance
“…The target compound 7 was successfully prepared from intermediate 15 by the sequential removal of allyl and acetyl groups. Moreover, the target molecule 8 was prepared by the coupling reaction of compound 11 with the sialic acid derivative 21 [29] in the presence of benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP) and N-methylmorpholine (NMM). All compounds were characterized by their 1 H NMR, 13 C NMR, and HRMS analyses.…”
Section: Chemistrymentioning
confidence: 99%
“…The target compound 7 was successfully prepared from intermediate 15 by the sequential removal of allyl and acetyl groups. Moreover, the target molecule 8 was prepared by the coupling reaction of compound 11 with the sialic acid derivative 21 [29] in the presence of benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP) and N-methylmorpholine (NMM). All compounds were characterized by their 1 H NMR, 13 C NMR, and HRMS analyses.…”
Section: Chemistrymentioning
confidence: 99%
“…Indeed, some 2-unsaturated congeners (glycals) of Neu5Ac have shown important inhibitory activity against various bacterial and viral sialidases (neuraminidases, NA), enzymes involved in the spreading of influenza infection. [11] Continuing our interest in the chemistry of Neu5Ac and NA inhibitors, [12][13][14][15][16][17][18] we herein report a simple procedure to access 4β-acylaminoglycals sharing the structure of compounds 3a and 3b, chosen as models in the synthetic protocol. [11] Continuing our interest in the chemistry of Neu5Ac and NA inhibitors, [12][13][14][15][16][17][18] we herein report a simple procedure to access 4β-acylaminoglycals sharing the structure of compounds 3a and 3b, chosen as models in the synthetic protocol.…”
Section: Introductionmentioning
confidence: 99%
“…
An efficient protocol for the 4β-acylamidation of the N-acylated glycals of Neu5Ac by using the corresponding N-perfluoroacylated congeners as key tools has been developed 2508 and applied to the synthesis of glycals combining the features of the molecules with antiviral properties.Continuing our interest in the chemistry of Neu5Ac and NA inhibitors, [12][13][14][15][16][17][18] we herein report a simple procedure to access 4β-acylaminoglycals sharing the structure of compounds 3a and 3b, chosen as models in the synthetic protocol. This appeared an attractive goal, as only a few methods involving the use of phosphane or palladium/phosphane catalysts allow these derivatives to be synthesized.
…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Methyl 5‐(Acetoxyacetamido)‐4,7,8,9‐tetra‐ O ‐acetyl‐3,5‐dideoxy‐2‐ O ‐methyl‐ D ‐ glycero ‐ D ‐ galcto ‐non‐2‐enonate (3e): Acetic anhydride (1.0 mL) was added dropwise to a stirred solution of 2‐ O ‐methyl‐5‐ N ‐glycolyl methyl β‐neuraminate23 (375 mg, 1.06 mmol) in anhydrous pyridine (2.0 mL) containing 4‐(dimethylamino)pyridine (ca. 1 mg) at 23 °C.…”
Section: Methodsmentioning
confidence: 99%